Central nervous system disease.
1Background: Previous studies raise the possibility that antioxidants protect against neurodegenerative diseases.
2Methods: It is a cross-sectional study with 44 patients with neurodegenerative diseases.
3Hypertension is a common age-related disease, along with vascular and neurodegenerative diseases.
4Such variability is elevated in neurodegenerative diseases or following traumatic brain injury.
5Memory decline during aging or accompanying neurodegenerative diseases, represents a major health problem.
6Moreover, these mechanisms provide useful therapeutic targets for the treatment of neurodegenerative diseases.
7Reduced activation of TrkB in particular is thought to contribute to neurodegenerative diseases.
8Today, molecular imaging of neurodegenerative diseases is mainly based on small molecule probes.
9These findings support the pharmacological potential of SMXZF for neurodegenerative diseases and stroke.
10Abnormal protein accumulation and aggregation is a common hallmark of many neurodegenerative diseases.
11These results contribute to the development of novel cellular therapies for neurodegenerative diseases.
12Glial dysfunction has been implicated in a number of neurodegenerative diseases.
13These have long been associated with neurodegenerative diseases, such as Alzheimer's.
14These factors are also of potential utility as therapeutic agents for neurodegenerative diseases.
15In neurodegenerative diseases and cervical spondylosis, only Mn SOD level was significantly elevated.
16Tauopathies are neurodegenerative diseases characterized by tau protein pathology in the nervous system.
Translations for neurodegenerative diseases